IOL CHEMICALS & PHARM. | WANBURY | IOL CHEMICALS & PHARM./ WANBURY |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | 22.3 | 61.4% | View Chart |
P/BV | x | 1.6 | - | - | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. WANBURY |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
WANBURY Mar-23 |
IOL CHEMICALS & PHARM./ WANBURY |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 90 | 599.7% | |
Low | Rs | 272 | 33 | 823.6% | |
Sales per share (Unadj.) | Rs | 377.6 | 152.8 | 247.2% | |
Earnings per share (Unadj.) | Rs | 23.7 | -3.2 | -745.7% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 0.6 | 5,190.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | -10.5 | -2,438.6% | |
Shares outstanding (eoy) | m | 58.71 | 32.71 | 179.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.4 | 267.0% | |
Avg P/E ratio | x | 17.1 | -19.3 | -88.5% | |
P/CF ratio (eoy) | x | 12.8 | 100.8 | 12.7% | |
Price / Book Value ratio | x | 1.6 | -5.8 | -27.1% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 2,004 | 1,184.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 810 | 207.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 4,996 | 443.7% | |
Other income | Rs m | 256 | 10 | 2,540.7% | |
Total revenues | Rs m | 22,427 | 5,007 | 448.0% | |
Gross profit | Rs m | 2,257 | 225 | 1,003.7% | |
Depreciation | Rs m | 462 | 124 | 372.7% | |
Interest | Rs m | 165 | 214 | 77.0% | |
Profit before tax | Rs m | 1,887 | -103 | -1,833.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 1 | 45,422.0% | |
Profit after tax | Rs m | 1,391 | -104 | -1,338.4% | |
Gross profit margin | % | 10.2 | 4.5 | 226.2% | |
Effective tax rate | % | 26.2 | -1.1 | -2,476.8% | |
Net profit margin | % | 6.3 | -2.1 | -301.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,222 | 791.3% | |
Current liabilities | Rs m | 5,025 | 3,204 | 156.9% | |
Net working cap to sales | % | 20.9 | -39.7 | -52.8% | |
Current ratio | x | 1.9 | 0.4 | 504.5% | |
Inventory Days | Days | 43 | 4 | 1,071.0% | |
Debtors Days | Days | 8 | 497 | 1.7% | |
Net fixed assets | Rs m | 11,017 | 1,742 | 632.3% | |
Share capital | Rs m | 587 | 327 | 179.5% | |
"Free" reserves | Rs m | 14,490 | -672 | -2,157.8% | |
Net worth | Rs m | 15,077 | -344 | -4,376.9% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 2,984 | 693.2% | |
Interest coverage | x | 12.5 | 0.5 | 2,398.9% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 1.7 | 64.0% | |
Return on assets | % | 7.5 | 3.7 | 204.1% | |
Return on equity | % | 9.2 | 30.2 | 30.6% | |
Return on capital | % | 13.6 | -32.2 | -42.2% | |
Exports to sales | % | 26.7 | 58.0 | 46.1% | |
Imports to sales | % | 0 | 20.5 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 2,899 | 204.5% | |
Imports (cif) | Rs m | NA | 1,024 | 0.0% | |
Fx inflow | Rs m | 5,930 | 2,997 | 197.9% | |
Fx outflow | Rs m | 6,052 | 1,072 | 564.6% | |
Net fx | Rs m | -122 | 1,925 | -6.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 198 | 617.6% | |
From Investments | Rs m | -1,200 | -88 | 1,357.8% | |
From Financial Activity | Rs m | -41 | -320 | 12.8% | |
Net Cashflow | Rs m | -18 | -210 | 8.7% |
Indian Promoters | % | 48.2 | 30.6 | 157.7% | |
Foreign collaborators | % | 0.0 | 9.2 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.2 | 944.4% | |
FIIs | % | 1.4 | 0.2 | 777.8% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 60.2 | 86.0% | |
Shareholders | 130,003 | 13,087 | 993.4% | ||
Pledged promoter(s) holding | % | 0.0 | 92.5 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | WANBURY | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.56% | -2.10% | 0.97% |
1-Month | 5.64% | 7.13% | 2.08% |
1-Year | -1.14% | 264.43% | 55.37% |
3-Year CAGR | -12.91% | 16.72% | 15.04% |
5-Year CAGR | 16.34% | 50.34% | 19.56% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the WANBURY share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of WANBURY the stake stands at 39.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of WANBURY.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
WANBURY paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of WANBURY.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.